Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 54474
Gene Symbol: KRT20
KRT20
0.080 Biomarker disease BEFREE HBV DNA monitoring-guided preemptive NAT was effective in preventing HBV-related hepatitis during anti-CD20-containing immunochemotherapy in B-cell NHL patients with resolved HBV infection. 30341058 2019
Entrez Id: 54474
Gene Symbol: KRT20
KRT20
0.080 Biomarker disease BEFREE In the current study, we developed a rituximab (anti-CD20)-modified mTOR inhibitor, AZD-2014, loaded into nanoparticles (Ab-NPs-AZD-2014) for trial of its anti-NHL effect. 30198340 2018
Entrez Id: 54474
Gene Symbol: KRT20
KRT20
0.080 Biomarker disease BEFREE Rituximab was administrated at 375 mg/m<sup>2</sup> on day 1 for CD20+ NHL. 28374163 2017
Entrez Id: 54474
Gene Symbol: KRT20
KRT20
0.080 Biomarker disease BEFREE Unvaccinated HBsAg-seronegative adults (n = 104) with CD20 NHL who had received rituximab-containing therapy without anti-HBV prophylaxis were enrolled. 26986131 2016
Entrez Id: 54474
Gene Symbol: KRT20
KRT20
0.080 Biomarker disease BEFREE The aim of this study was to analyze expression of complement inhibitors CD46, CD55, and CD59 in patients with CD20(+) NHLs treated with rituximab combined with chemotherapy. 19662541 2010
Entrez Id: 54474
Gene Symbol: KRT20
KRT20
0.080 AlteredExpression disease BEFREE Ten patients (age 31-70 years, mean 50 years) were included, nine with CD20 B-cell NHL and one with CD20-NHL. 18987526 2008
Entrez Id: 54474
Gene Symbol: KRT20
KRT20
0.080 Biomarker disease BEFREE To determine the safety and efficacy of the combination of the chimeric anti-CD20 antibody Rituxan (rituximab, IDEC-C2B8; Genentech Inc, South San Francisco, CA) and cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy in patients with aggressive non-Hodgkin's lymphoma (NHL). 11208830 2001
Entrez Id: 54474
Gene Symbol: KRT20
KRT20
0.080 AlteredExpression disease BEFREE A biopsy from the recurrent tumor after two courses of rituximab revealed a diffuse large cell NHL where 0% of B cells expressed CD20 with no evidence of bound rituximab. 10100713 1999